Cenova Capital Leads Series A Round In Chinese AI Medical Firm Phoebus

Phoebus Medical Technology, an artificial intelligence-based chronic disease management company, has raised tens of millions of RMB in series A round of financing from healthcare and life sciences-focused Cenova Capital, according to Chinese media reports.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

China Expert network